Figure 1:
Long-term outcomes in adult allogeneic HCT survivors with AML, ALL, CML, and MDS who had survived in remission ≥1 year in remission by race/ethnicity: (A) Overall survival, (B) Relapse, and (C) Non-relapse mortality
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.